Investegate |Renalytix PLC Announcements | Renalytix PLC: Director/PDMR Shareholding
Investegate announcements from Renalytix PLC, Director/PDMR Shareholding
Source: investegate.co.uk
Page 25 - Breakthrough Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Designation Today - Breaking & Trending Today
Renalytix Reports Financial Results for First Quarter of
NEW YORK and SALT LAKE CITY, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro...
Source: globenewswire.com
FDA Grants Breakthrough Designation for Nyxoah Genio System for Obstructive Sleep Apnea & Complete Concentric Collapse
The FDA will provide the Genio system with priority review and interaction with FDA’s experts throughout the premarket review phase until the product is commercialized in the United States.
Source: sleepreviewmag.com
Investegate |Renalytix PLC Announcements | Renalytix PLC: Notice of Q1 FY22 Results
Investegate announcements from Renalytix PLC, Notice of Q1 FY22 Results
Source: investegate.co.uk
Pharmadrug Inc.: Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its Cepharanthine for Treatment of Mild to Moderate COVID-19 Infection
Established alignment with FDA on the path forward for the development of PD-001, a patented enteric-coated formulation of cepharanthine, towards clinical studies for mild-moderate COVID-19 infectionMeeting
Source: finanznachrichten.de